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Abstract
Enterovirus (EV) 71 infection is known to cause hand-foot-and-mouth disease (HFMD) and in severe cases, induces
neurological disorders culminating in fatality. An outbreak of EV71 in South East Asia in 1997 affected over 120,000 people
and caused neurological disorders in a few individuals. The control of EV71 infection through public health interventions
remains minimal and treatments are only symptomatic. Recently, human scavenger receptor class B, member 2 (SCARB2)
has been reported to be a cellular receptor of EV71. We expressed human SCARB2 gene in NIH3T3 cells (3T3-SCARB2) to
study the mechanisms of EV71 entry and infection. We demonstrated that human SCARB2 serves as a cellular receptor for
EV71 entry. Disruption of expression of SCARB2 using siRNAs can interfere EV71 infection and subsequent inhibit the
expression of viral capsid proteins in RD and 3T3-SCARB2 but not Vero cells. SiRNAs specific to clathrin or dynamin or
chemical inhibitor of clathrin-mediated endocytosis were all capable of interfering with the entry of EV71 into 3T3-SCARB2
cells. On the other hand, caveolin specific siRNA or inhibitors of caveolae-mediated endocytosis had no effect, confirming
that only clathrin-mediated pathway was involved in EV71 infection. Endocytosis of EV71 was also found to be pH-
dependent requiring endosomal acidification and also required intact membrane cholesterol. In summary, the mechanism
of EV71 entry through SCARB2 as the receptor for attachment, and its cellular entry is through a clathrin-mediated and pH-
dependent endocytic pathway. This study on the receptor and endocytic mechanisms of EV71 infection is useful for the
development of effective medications and prophylactic treatment against the enterovirus.
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Introduction
Enterovirus 71 (EV71), a positive single stranded RNA virus
belonging to the family of Picornaviridae is known to manifest hand-
foot-and mouth disease (HFMD) in young children, and can lead to
the development of severe neurological diseases including aseptic
meningitis, cerebellar encephalitis, and acute flaccid paralysis
culminating in fatality in some patients especially children [1,2,
3,4,5]. The first EV71 infection was recorded in California in 1969
[6], and then opened an outbreak in Bulgaria in 1975 resulted in 44
fatal cases [7], also reported 47 fatalities in Hungary in 1978 [8], 34
fatalities in Malaysia in 1997 [1,9], 78 fatalities in Taiwan in 1998
[10,11]. Following epidemics in Taiwan that caused 25 deaths in
2000, 26 deaths in 2001, and 14 deaths in 2008 [12,13,14], and
more cases of EV71 infection are sporadically reported in many
countries. Till now the treatment and control of EV71 infection are
only symptomatic due to the lack of effective medications and
unavailability of a prophylactic vaccine [15].
Two different membrane proteins, human P-selectin glycopro-
tein ligand-1 (PSGL-1; CD162) [16] and human scavenger
receptor class B, member 2 (SCARB2) [17] have been identified
as cellular receptors for EV71. PSGL-1 is a sialomucin membrane
protein widely expressed in leukocytes that plays a role in early
stages of inflammation [18,19,20]. SCARB2, also called lysosomal
integral membrane protein 2 or CD36b like-2, has two
transmembrane domains with the N and C termini located in
the cytosol [21]. It is expressed in many tissues, participates in
membrane transport and the reorganization of the endosomal/
lysosomal compartment [22] and high density lipoprotein
endocytosis (HDL) [23]. Based on their PSGL-1-binding capabil-
ity, different EV71 isolates are classified into PSGL-1-dependent
and PSGL-1-independent strains. SK-EV006 (genogroup B3),
C7/Osaka (B4), KED005 (C1), 1095 (C2) and 75-Yamagata (C4)
are PSGL-1-dependent strains. BrCr (genogroup A), Nagoya (B1),
and 02363 (C1) are PSGL-1-independent isolates [16,24]. Some
EV71 strains such as BrCr (A), Nagoya (B1), and Isehara (C) have
been reported to utilize SCARB2 as a receptor. Expression of
human SCARB2 receptor in unsusceptible cell lines was found to
facilitate these strains of EV71 and coxsackievirus A16 (CVA16)
infection resulting in the development of cytopathic effects [17].
Viruses enter into host cells through endocytosis followed fusion
of the viral envelope with the endosomal membrane facilitating
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30507delivery of the viral genome into the cytosol. Although the
endocytic pathways used by some viruses, such as influenza virus
[25], hepatitis C virus (HCV) [26], respiratory syncytia virus
(RSV) [27,28], severe acute respiratory syndrome coronavirus
(SARS-CoV) [29], vesicular stomatitis virus (VSV) [30,31], simian
virus 40 (SV40) [32], Ebola virus [33], and echovirus I [34] have
been determined. Viruses entering cells through clathrin- or
caveolin-mediated endocytosis, as well as clathrin- and caveolin-
independent pathways have been reported [35,36,37]. In clathrin-
mediated endocytosis, virus-bound receptors are targeted to
clathrin-coated pits (CCPs), which mature into clathrin coated
vesicles (CCVs) resulting in the internalization of viruses with their
receptors. Caveolin-mediated endocytosis is also a well-character-
ized process, which involves the association of glycolipid rafts of
plasma membrane with caveolins resulting in their internalization
[37]. Dynamins, the large GTPase of molecular size 100 KDa are
involved in the budding and scission of nascent vesicles from the
parent membranes during clathrin-mediated endocytosis [38,39].
Several studies have identified the recruitment of dynamin to the
neck of nascent CCVs prior to fission [40,41,42]. Additionally,
dynamins have been implicated in the budding of caveolin,
phagocytosis and vesicle cycling at the neuron-muscular junction
[43]. Recent study has mapped the encoding sequence at the
region of amino acid 142 to 204 of human SCARB2 that is critical
for EV71 binding and infection [44]. The clathrin-mediated
endocytosis as the entry pathway for EV71 infection was identified
[45]. However, the detail of receptor-mediated entry mechanism
for EV71 has still needs more exploration.
Our investigation focuses on the entry mechanism of EV71 in
SCARB2-expressing cells. We have infected the SCARB2-
overexpressing NIH3T3 cells (3T3-SCARB2), RD, and Vero cells
with EV71/E59 strain, a B4 sub-genotype isolated in Taiwan in
2002. Expression of SCARB2 had made the 3T3-SCARB2 and
RD cells susceptible to EV71 infection, proving that SCARB2 is a
functional receptor of EV71. Both viral infection and replication
was well supported in 3T3-SCARB2 and RD cells, while
SCARB2-independent EV71 susceptibility was observed in Vero
cells. We demonstrates that EV71 entry into 3T3-SCARB2 is
through clathrin-dependent endocytosis which was inhibited
significantly by knocking down the clathrin or dynamin expression
using specific siRNAs or by using inhibitors of clathrin-dependent
endocytosis. Moreover, the examined endocytosis of EV71 is pH-
dependent as it was inhibited by endosomal acidification
inhibitors. Taken together, our results demonstrate that EV71
binds to SCARB2 and triggers a clathrin- and dynamin-dependent
endocytosis for its entry.
Materials and Methods
Cell culture
African green monkey kidney (Vero) (ATCC No. CCL-81) and
human rhabdomyosarcoma (RD) (ATCC No. CCL-136) cells
were provided by the Taiwan Centers of Disease Control (Taiwan
CDC); the original cell lines were obtained from the American
Type Culture Collection (ATCC). A549 (ATCC No. CCL-185), a
human lung adenocarcinoma lines, were purchased from ATCC.
NIH3T3 mouse fibroblast cells (ATCC No. CRL-1658) were
kindly obtained from Dr. Pele Chong, National Institutes of
Infectious Disease and Vaccinology, National Health Research
Institutes, Taiwan. The original NIH3T3 cell lines were purchased
from ATCC. Vero cells were cultured in VP-SFM medium
(GIBCO) supplemented with 5% fetal bovine serum (FBS)
(Biological Industries), and 1% penicillin/streptomycin (P/S)
(Biological Industries). NIH3T3, RD and A549 cells were grown
and maintained in Dulbecco’s modified Eagle’s medium (Hyclone)
plus 10% FBS, and 1% P/S. Cells were maintained in an
incubator at 37
oC and equilibrated with 5% CO2.
NIH3T3 cells at 80% confluency were transfected with pCMV-
SCARB2 plasmid by cationic polymer-DNA transfection method.
NIH3T3 cells were grown in a 12-well plate, and 0.5 mgo f
plasmid DNA pre-mixed with 1 mL of TurboFect transfection
reagent (Fermentas) was added to 50 mL culture medium for each
well and then cultured in the incubator for 24 hours. Stable cells
overexpressing SCARB2 were selected in the presence of 800 mg/
ml of G418 (Sigma-Aldrich). Stable cell line 3T3-SCARB2 was
established by expansion of a single cell originally cultured in 96-
well plate in the presence of G418 after two weeks of culture.
Plasmids and viruses
Human SCARB2 gene sequence published recently [17] was
codon-optimized and synthesized commercially by GENEART,
Germany and inserted into pcDNA3.1(-) vector (Invitrogen)
containing enhancer/promoter of cytomegarovirus (CMV), simian
virus 40 (SV40) poly A tail, and neomycin-resistant gene, at
EcoRI/BamHI cloning site to obtain pCMV-SCARB2 plasmid.
EV71/E59 strain, a B4 sub-strain isolated in Taiwan in 2002 by
Taiwan CDC was propagated in Vero or 3T3-SCARB2 cells.
Briefly, 2610
6 cells cultured in a 10-cm dish were infected with
live EV71/E59 virus at a MOI (multiplicities of infection) of
1610
23. The culture supernatant was harvested 5 days after
infection and passed through a 0.45 mm filter (Sartorius) to remove
the cell debris. The culture supernatant was tested in a standard
virus plaque forming assay to determine its infectious viral content.
It was aliquoted and stored at 280uC as the viral stock.
Recombinant lentivirus-eGFP which carries green fluorescence
protein (GFP) was obtained from the National RNAi Core Lab in
Genomics Research Center of Academia Sinica, Taiwan.
Flow cytometry
1610
6 NIH3T3, 3T3-SCARB2, Vero, and RD cells were
harvested from trypsin-free dissociation buffer (GIBCO) treated
culture dishes and spun down to remove the supernatant. Cells
were washed once with 16PBS (pH=7.4) and then fixed with
permealization/fixation solution (70% ice-cold methanol in PBS)
or non-permealization/fixation solution (0.5% paraformalydehyde
in PBS) for overnight. The cells were washed, and 1 mL of 1 to
1000 dilution of biotinylated anti-SCARB2 antibody (R&D) was
added and incubated at 4uC for 1 hour. After incubation, the cells
were washed and stained with 1:2000 diluted fluorescence
isothiocyanate (FITC)-conjugated streptavidin (Biolegend) for
30 minutes. SCARB2-expressing cells were detected using FACS-
can flow cytometer and analyzed using the CellQuest software
(Becton Dickinson Immunocytometry System). 3T3-SCARB2 cells
stained only with FITC-streptavidin were used as conjugate
control for deducting the background.
EV71- specific enzyme-linked immunosorbent assays
(ELISA)
Cells cultured at a density of 10
4 per well in 96-well plate were
incubated with varied MOIs of EV71 in 100 mL of serum-free
DMEM medium for one hour at 37uC. After one hour of
infection, the cells were washed three times with 16PBS
(pH=7.2), and cultured in 1serum-free DMEM for another
24 hours. Cells were washed again with 16PBS (pH=7.2) and
then fixed with 100 mL of 100% methanol for 30 minutes at room
temperature, and then 250 mL of 5% skim milk-PBS was added to
each well to block the non-specific binding of the detection
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the E1 monoclonal antibody, produced from a hybridoma line
generated from EV71/E59-immunized BALB/c mouse at Na-
tional Health Research Institutes, vaccine Center, Taiwan)
prepared in PBS containing 5% skim milk was added to each
test well to detect the viral capsid proteins. After 2 hours
incubation at room temperature, the plate was washed four times
by pipeting 250 mL of 1x PBS into the individual wells. 100 mLo f
HRP-conjugated anti-mouse IgG (Jackson ImmunoResearch)
diluted at 1 in 5,000 in assay buffer was then added to each well
and incubated for I hour at room temperature before washing the
plate four times with 1x PBS. 70 mL of TMB peroxidase substrate
(SureBlue
TM, KPL) was added to the individual assay well and
allowed to react for 30 min at room temperature. The reaction
was stopped by adding 70 mL2 NH 2SO4 to each well and the
absorbance was recorded at OD 450 nm using an ELISA reader
(Spectra Max M2 model, Molecular Devices, USA).
Antibodies and western blot
Anti-VP2 specific monoclonal antibody, MAB979, was obtained
from Millipore-Chemicon International. Anti-SCARB2 antibody
was purchased from R&D. Antibodies specific to clathrin and
dynamin were purchased from Abcam and Santa Cruz Biotech-
nology, Inc., respectively. Anti-caveolin-1 antibody was purchased
from Cell signaling. De novo synthesis of VP1 and VP2 in EV71-
infected cells and expression of SCARB2 in the cells were assessed
by Western blot.
Cell lysates were prepared by treatment of 122610
6 cells in
100 mL of ice-cold lysis buffer (0.5% sodium deoxycholate, 0.1%
sodium dodecyl sulfate (SDS), 0.5% NP-40, 50 mM TRIS,
150 mM NaCl) with the addition of a protease inhibitors cocktail
(Roche) and 1 mM PMSF (Sigma-Aldrich). Lysates were then
centrifuged for 20 min at 10,000 rpm, at 4
oC to sediment cell
debris. Cell lysate was subjected to SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) (Amersham Biosciences). This en-
tailed loading 10 mg of the cell lysate mixed with loading dye per
well of a 10% SDS-PAGE. Following electrophoresis at 100 V for
90 minutes in 1X Tris-glycine SDS-running buffer, the resolved
proteins were transferred onto a nitrocellulose membrane
(Hybond-ECL, Amersham Biosciences). Protein-containing mem-
brane was soaked in 5% skim milk in PBS, pH 7.4 for 30 min at
room temperature, then washed three times with 10 mL of assay
buffer [PBS, pH 7.4 containing 0.05% Tween 20]. The
membrane was incubated with 1: 5000 diluted MAB979, or 1:
2000 diluted anti-SCARB2 antibody, for 14–16 hours at 4uC, and
subsequently washed 5 times with 15 mL of assay buffer followed
by incubation with horse radish peroxidase (HRP) conjugated
donkey anti-mouse secondary antibody (Jackson ImmunoRe-
search) at a dilution of 1 in 5,000 (for MAB979), or HRP-
conjugated anti-goat secondary antibody (Jackson ImmunoRe-
search) at a dilution of 1:5,000 (for anti-SCARB2 antibody). After
1 hour incubation at room temperature, the membrane was
washed 5 times with the assay buffer, and 1 mL of Super Signal
West Pico chemiluminescent substrate (Pierce) was then layered
onto the membrane. The reaction was detected by exposing the
membrane to an X ray film (Kodak) at 30 sec, 1, 3, and 5 minutes
intervals. When necessary membranes were stripped with restoring
buffer (Pierce) and used again with another antibody.
Co-Immunoprecipitation
400 mg of cell lysates from 3T3-SCARB2 and parental 3T3 cells
were mixed with 3610
6 pfu of EV71 and incubated at 4uC for 1 h
with occasionally rocking. Following lysate-viruses mixtures was
rocked with 20 mL of protein G agarose beads (Santa Cruz
Biotechnology) and 1 mg of anti-SCARB2 antibody at 4uC for
3.5 hours. After five washes with lysis buffer, beads were
resuspended in 50 mL SDS loading buffer, boiled for 5 min and
then 10 uL of samples were taken and subjected to SDS-PAGE
and western blotting with anti-EV71 MAB 979 antibody.
Detection was achieved by using appropriate secondary antibodies
labeled with horseradish peroxidase as described above. Each
experiment has been repeated at least two times independently.
Immune plaque forming assay
The assay was carried out by seeding 1.5610
5 NIH3T3, 3T3-
SCARB2, Vero, or RD cells in individual wells of a 12-well tissue
culture plate (Corning). 500 mLo f1 0
3 to 10
8 dilutions of EV71/
E59 in serum-free culture medium was then added to each well
followed by one hour incubation at 35
oC. 1 mL of 2.0% methyl
cellulose in DMEM was overlaid onto the cells. The cultures were
kept in a 35
oC incubator equilibrated with 5% CO2 for 5 days.
Development of plaques was detected by removing the superna-
tant, washing the cells once with cold PBS, and treating them with
0.5 mL of 2.0% paraformaldehyde (Merck). Fixation was allowed
by incubating the plate at 4
oC for 10 minutes. Fixation buffer was
removed and 250 mL of assay buffer containing 1 in 5,000 dilution
of the E1 monoclonal antibody was then added to the individual
test well. The assay plates were incubated for 1 hour at 37
oC for
E1 antibodies to bind to the viral VP1 capsid protein, expressed on
EV71-infected cells. Individual test wells were then washed 3 times
with 0.5 mL of assay buffer. 100 mL of an anti-mouse IgG-HRP
(horse radish peroxidase) conjugated antiserum (Jackson Immu-
noResearch) at 1 in 5,000 dilution prepared in assay buffer was
added to each test wells. After leaving the plates for 1 hour
incubation at room temperature, the test wells were washed three
times with the assay buffer. The plates were blotted dry on paper
towel, 100 mL of TMB substrate (KPL) was added to the
individual assay wells and then the plates were incubated in dark
for 30 minutes. The plaques representing cells infected by EV71
virus were seen as black spots in each test well and their number
was taken for calculating plaque-forming units (pfu) to represent
the virus infectivity.
Down-regulation of cellular gene expression by siRNA
3T3-SCARB2 cells at 80% confluency were transfected with
oligonucleotides of siRNA specific to target gene or the control
siRNA by liposome-oligonucleotide transfection method. Briefly,
50 mL culture medium containing 50 or 100 pmoles of siRNA pre-
mixed with 1 mL of TurboFect siRNA transfection Reagent
(Fermentas) was added per well of a 12-well plate and incubated
at 37
oC for 24 or 48 hours in an incubator. After incubation, the
cells were infected with EV71 (MOI=0.04) in serum-free culture
medium followed by 1 hour incubation at 37
oC before washing
three times with serum-free culture medium.After 24or48 hoursof
incubation, cells lysates were prepared for western blot. SCARB2
siRNA (sc-41546) was purchased from Santa Cruz Biotechnology,
Inc. SiRNAs specific to mouse clathrin light chain B (Gene bank
Accession No. M20469) (One-TARGET plus SMART pool, Cat.
No. L-046978-01-0005), mouse dynamin 2 (Gene bank Accession
No. L36983) (One-TARGET plus SMART pool, Cat. No. L-
044919-02-0005), mouse caveolin-1 siRNA (Invitrogen), and
negative control siRNA were purchased from Invitrogen. The blots
were quantified using Image –Pro Plus 6.0software.
Inhibition of endocytosis and endosomal acidification
1610
5 3T3-SCARB2cells seededina 12-well plate one day prior
to the experiments were treated with various concentrations of
inhibitor for one hour and then infected with EV71 (MOI=0.04) in
Mechanism of EV71 Entry in SCARB2-Expressing Cells
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inhibitor. The cells were washed three times with serum-containing
culture medium and after additional 24 hours of culturing in the
presence of the inhibitor, the cells were harvested and lysed for
immunoblotting using MAB979 antibody. For lentivirus-eGFP
infection, 4610
5 A549 cells were seeded in a 12-well plate one day
prior to the treatment with genistein (dissolved in 0.1% DMSO) or
vehicle alone for one hour and then infected with lentivirus-eGFP
(MOI=0.1). After infection, cells were washed and then following
cell culture until 72 hours. Without infection with lentivirus-eGFP
of A549 cells were included as GFP negative control. The same field
of fluorescent and visible pictures was taken under the UV-
fluorescent microscopy (Olympus DP70) and GFP-positive cells
were counted. For the assay of the internalization of cholera toxin
subunit B (CT-B), 1610
5 3T3-SCARB2 cells were grew on a
coverslipone dayand then washedtoremoveanyserumpriortothe
treatment with filipin (dissolved in 0.1% DMSO vehicle) or vehicle
alone for one hour at 37
oC. All subsequent incubations contained
the inhibitors. Cells were cooled to 15
oC and then incubated with
5 mg/mL alexa fluor 594 CT-B conjugate (dissolved in 0.1%
DMSO) (Invitrogen). After 30 minutes incubation, cells were
washed and either fixed immediately. The cells were fixed with
4% paraformaldehyde for 20 minutes at 37
oC and washed three
timesinPBS.Theslideswerethen mounted witha coverslipand the
cells observed in the same field of fluorescent and visible pictures
was taken by the confocal microscopy (Leica TCS SP5 II).
Depletion of cholesterol from the plasma membrane using
MbCD was done as described [46]. Cells were treated with serial
dilutions of MbCD for 30 minutes prior to the infection with
EV71 as described above.
The following compounds used as inhibitors were purchased
from Sigma-Aldrich, St Louis, MO, USA: genistein, filipin, methyl
b-cyclodextrin (MbCD), chloroquine, and ammonium chloride
(NH4Cl). chlorpromazine (CPZ) was obtained from Alexis
Biochemicals.
Results
Expression of SCARB2 in transfected NIH3T3 cells
To explore the role of SCARB2 while EV71 virus entry, EV71
virus was cultivated in RD and Vero cells that already express
SCARB2 and in NIH3T3 cells engineered to express human
SCARB2. Human SCARB2 gene was cloned into pCMV
expression vector under the CMV promoter to obtain pCMV-
SCARB2 plasmid. NIH3T3 cells which are naturally not
susceptible to EV71 were transfected with pCMV-SCARB2
plasmid and selected with G418 to establish a stable SCARB2-
expressing cell line, 3T3-SCARB2.
The expression levels of SCARB2 in Vero, RD and 3T3-
SCARB2 cells were examined by Western blotting using a
polyclonal antibody specifically against the cytosolic domain of
SCARB2. The expressed SCARB2 protein was identified to have
a molecular weight of 80 KDa and the determined expression level
was very high in 3T3-SCARB2, moderate in RD cells, but very
little in Vero cells. No SCARB2 was detected in the cell lysate
from NIH3T3 cells (Fig. 1A). The following treatment of cells with
Figure 1. Expression of SCARB2 in RD, Vero, NIH3T3, and 3T3-SCARB2 cells. (A) Lysates prepared from the tested cells were analyzed by
immunoblotting using a polyclonal rabbit anti-SCARB2 antiserum. The SCARB2 protein has molecular size of 80 KDa. The internal cellular b-actin was
detected by blotting the stripped membrane with monoclonal anti-b-actin antibody which corresponded to 44 KDa products. (B) The tested cells
were incubated with biotinylated anti-SCARB2 antiserum (filled curve) or without antiserum (empty curve) prior fixed by methanol and then stained
with FITC-conjugated avidin. Stained cells were run on a FACScan flow cytometer and analyzed by using CellQuest software (Becton Dickinson
Immunocytometry System).
doi:10.1371/journal.pone.0030507.g001
Mechanism of EV71 Entry in SCARB2-Expressing Cells
PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e30507permealization/fixation solution and then analyzed by flow
cytometry also confirmed the cytosolic expression of SCARB2 in
3T3-SCARB2, RD, and Vero cells (Fig. 1B). However, flow
analysis of NIH3T3, 3T3-SCARB2, RD, and Vero cells that pre-
treated with a non-permealization/fixation solution to maintain
the intact membrane structure could not detect SCARB2 on the
surface (data not shown). It is probably due to SCARB2
dynamically cycling between the endosomal/lysosomal compart-
ments and plasma membrane while transports cellular proteins
from outside of cells into the cells [23]. Moreover, another
identified EV71 receptor, PSGL-1, usually expressed in leukocytes
[16]. Our RT-PCR analysis also revealed that NIH3T3, Vero and
RD cells did not express PSGL-1 (data not shown).
SCARB2 expression in 3T3-SCARB2 facilitates EV71
infection
To confirm that SCARB2 expression per se facilitates infection
with EV71 virus, 3T3-SCARB2, RD, Vero and NIH3T3 cells
were inoculated with two concentrations of EV71 virus and
examined for viral infection. Cytopathic effects were observed in
3T3-SCARB2, RD, and Vero cells. The expression of EV71
capsid proteins namely VP2 and VP4 in the infected cells was
demonstrated by western blot using a VP2-specific monoclonal
antibody MAB979 which has been identified [47]. Previous studies
showed that multiple capsid proteins of VP0 (38 KDa, a precursor
product of VP2+VP4), VP1 (36 KDa), VP2 (28 KDa), VP3 (25
KDa) and VP4 (8 KDa) were detected in the EV71-infected cells
[48,49,50]. Corroborating these findings, we observed that 3T3-
SCARB2, Vero and RD cells infected with EV71 were able to
express capsid proteins with molecular weights in the range of 38
KDa (for VP0), and 28 KDa (for VP2), and 25 KDa (for VP3)
(Fig. 2A). In NIH3T3 cells, neither the cytopathic effect nor the
expression of viral capsid proteins was seen confirming that these
cells were unsusceptible to EV71 infection and that SCARB2
expression had converted it into a susceptible cell line. The
expression level of viral capsid protein was found to synchronize
with the increase in multiplicity of infection (MOI) of EV71 from
0.04 to 1. The level of expression of viral capsid protein was the
highest in 3T3-SCARB2 cells, moderate in RD cells and the
lowest in Vero cells, in which were corresponding to the individual
Figure 2. Susceptibility of SCARB2-expressing cells infected with EV71. (A) Four different cells, NIH3T3, 3T3-SCARB2, RD, and Vero cells,
were infected with two different MOI of EV71 and then cultured for 48 hours. After incubation, cell lysates were prepared for western blot using anti-
capsid MAB979 antibody. (B) Immune plaque forming assay was performed in four different cells infected with 10-fold serial diluted 10
8 pfu/ml stocks
of EV71 as described in the Materials and Methods. The immuno-stained plaques were counted and photography was taken. (C) NIH3T3 or SCARB2-
expressing NIH3T3, RD, and Vero cells cultured in 96-well plate were inoculated with various MOI of EV71 for one hour at room temperature. After
incubation, cells were washed three times with PBS and then cultured for another 24 hours before fixed by methanol. EV71 capsid protein in the cells
was detected by ELISA assay as described in the materials and methods.
doi:10.1371/journal.pone.0030507.g002
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between SCARB2 expression and susceptibility to EV71.
The correlationship was further investigated by infecting
NIH3T3, 3T3-SCARB2, Vero, and RD cells with serial dilutions
(10
23 to 10
28 pfu) of EV71 followed by determination of plaque
formation by immuno-plaque assay. We observed that 3T3-
SCARB2 with the highest level of SCARB2 expression (Fig. 1A)
was susceptible to ,1610
28 dilution of EV71 whereas RD cells
with moderate expression were susceptible to ,5610
27 dilution of
EV71. Interestingly, Vero cells with the lowest level of SCARB2
expression acquired ,3610
27 dilution of EV71 to get infected
(Fig. 2B), and as expected, no plaques were formed in NIH3T3
cells, which were unsusceptible. Moreover, ELISA assay to
compare the cell susceptibility for EV71 infection was also
performed (Fig. 2C) as described in the Materials and Methods.
By using E1 antibody against EV71 VP1 [47], 3T3-SCARB2 cells
expressed the highest EV71 capsid protein was detected in a dose-
dependent manner. No EV71 capsid protein was detected in
NIH3T3 cells which do not express SCARB2. RD cells showed
the moderate expressed EV71 virus. Nevertheless, Vero cells could
be efficiently infected with EV71 virus (Fig. 2C), in spite of their
low levels of SCARB2 (Fig. 1A). By comparison of the order of the
susceptibility to EV71 infection (3T3-SCARB2.Vero.RD) with
the level of SCARB2 expression (3T3-SCARB2.RD.Vero), it is
possible that Vero cells possess other binding proteins to support
EV71 infection.
Our results not only confirm the role of SCARB2 as a receptor
for EV71 infection but also demonstrate that the degree of
susceptibility to EV71 depends on the expression levels of
SCARB2 in the cells.
Interaction of EV71 capsid protein with SCARB2 receptor
To examine whether SCARB2 interacts with EV71 in the cells,
co-immunoprecipitation of EV71 virions with SCARB2 in the
3T3-SCARB2 protein was performed. Cell extracts prepared from
3T3-SCARB2 or NIH3T3 cell line was mixed with excess EV71
viral particles to allow the virus to associate with SCARB2. The
complex was then immunoprecipitated using protein G-conjugat-
ed anti-SCARB2 antibody. Western blotting of precipitates with
anti-EV71 MAB979 demonstrated that EV71 virions were
precipitated from 3T3-SCARB2 cells but not from control
NIH3T3 cells (the top panel of Fig. 3), compared to immuno-
blotting of lysate-viruses mixtures from both cell lines that
corresponding EV71 capsid protein were observed. SCARB2
was detected in co-immunoprecitates and lysate-viruses mixtures
from 3T3-SCARB2 but not NIH3T3 cells while the same
membrane was stripped and then re-blotted with anti-SCARB2
antibody (the bottom panel of Fig. 3), confirming that SCARB2
interacting with EV71 capsid protein could be pulled down from
3T3-SCARB2 but not from NIH3T3 cells. This result demon-
strates that SCARB2 does associate with EV71 and therefore acts
as a cellular receptor for EV71 infection.
Knocking down SCARB2 inhibits EV71 infection
To further prove that SCARB2 is the key protein supporting
EV71 infection, endogenous SCARB2 expressed in RD and Vero
cells was knocked down using SCARB2-specific siRNA. Cells were
transfected with SCARB2 siRNA followed by 24 or 48 hours of
incubation (t24 or t48), and subsequently infected with EV71
(MOI=0.04) for 24 or 48 hours (i24 or i48). SCARB2 expression
level in siRNA-transfected cells was monitored at 24 or 48 hours
after transfection by Western blot using anti-SCARB2 antibody. It
was found that expression of SCARB2 was reduced by almost
100% in RD cells transfected with 100 pmoles of SCARB2 siRNA,
compared to control siRNA-transfected cells (the top panel of
Fig. 4A). However, the expression of EV71 capsid protein in
infected RD cells was completely inhibited upon transfection with
100 pmoles of SCARB2 siRNA, while the capsid protein
expression was significantly reduced in cells transfected with 50
Figure 3. Association of EV7 with SCARB2 in 3T3-SCARB2 cells.
Lysates prepared from the 3T3-SCARB2 and NIH3T3 cells were mixed
individually with EV71 particles and then precipitated by protein G-
conjugated anti-SCARB2 antibody as described in the Materials and
Methods. Lysate-viruses mixtures without treatment of co-immunopre-
cipitation were also prepared. Following the co-precipitates and lysate-
virus mixtures were individually subjected to western blot against
associated EV71 capsid protein by blotting with MAB979 antibody (the
top panel). The same membrane was stripped and re-blotted with ant-
SCARB2 antibody.
doi:10.1371/journal.pone.0030507.g003
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capsid protein was not affected in mock-transfected cells.
A similar experiment performed in Vero cells revealed that
transfection with 50 or 100 pmoles of SCARB2 siRNA had no
inhibitory effect on the synthesis of EV71 capsid proteins (the
bottom panel of Fig. 4B), even though the ,100% of SCARB2
expression was inhibited by siRNA transfection (the top panel of
Fig. 4B). These findings suggest that SCARB2 is the major
receptor for EV71 infection in RD cells but not in Vero cells,
where other unidentified proteins function as receptor for EV71
infection.
Cellular entry of EV71 is dependent on clathrin and
dynamin
SCARB2 is known to induce clathrin-, but not caveolae-,
mediated endocytosis in the internalization of HCV into target
cells [51], and in HDL endocytosis [23]. In an attempt to unravel
the mechanism of EV71 entry into 3T3-SCARB2 cells, several
compounds known to inhibit clathrin- and caveolin-mediated
endocytosis were used to annotate the pathway involved in EV71
entry. Chlorpromazine (CPZ) is a cationic amphiphilic reagent
that inhibits the assembly of clathrin-coated pits at the plasma
membrane [52,53]. It has been used to test out clathrin-mediated
endocytosis in many viruses such as influenza virus [25], HCV
[26], SARS-CoV [29], VSV [30], and RSV [27]. 3T3-SCARB2
cells pretreated with various concentrations of CPZ showed a
dose-dependent reduction in the synthesis of de novo capsid proteins
following EV71 infection. Significant inhibition of capsid protein
synthesis was observed at CPZ concentration of 5.0 mg/mL
(Fig. 5A). These findings suggest that clathrin-mediated endocy-
tosis played a crucial role in EV71 entry.
To further examine EV71 entry is clathrin-dependent course,
endogenous clathrin expression in 3T3-SCARB2 cells was
knocked down using clathrin light chain B (CLTB)-specific siRNA.
Downregulation of cellular 30 KDa of CLTB expression was
observed at 24 and 48 hours after transfection with 100 pmoles of
clathrin-specific siRNA, compared to mock-transfected cells (the
top panel of Fig. 5B). It was observed that 100 pmoles of clathrin
Figure 4. Infection of EV71 in RD cells but not Vero cells is SCARB2-dependent. (A) RD cells, and (B) Vero cells were transfected with two
different amount of SCARB2 siRNA and then incubated for 24 or 48 hours before MOI=0.04 of EV71 infection. Lysates prepared at 24 or 48 hours
after siRNA transfection were subjected to western blot using anti-SCARB2 antibody (the tope panel). Cell lysates were extracted at 24 or 48 hours
after EV71 infection and subjected to detect the synthetic viral capsid protein by western blot using MAB979 antibody (the lower panel). The internal
control of cellular b-actin was detected by blotting the same membrane with monoclonal anti-b-actin antibody. Corresponding changes in SCARB2
protein levels compared to the expression levels in 48 hours transfection of the cells with 100 pmoles control siRNA (Mock) as 1.0 were quantified
using Image-Pro Plus 6.0 software. Data represent one of two independent experiments.
doi:10.1371/journal.pone.0030507.g004
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48 h post transfection (the bottom panel of Fig. 5B). These results
prove that EV71 entry into 3T3-SCARB2 cells is facilitated by
clathrin-mediated endocytosis.
Dynamin family proteins have been reported to tabulate and
save membrane-coated vesicles and plays a role in membrane
fission that associated with clathrin-dependent and clathrin-
independent endocytic processes [38,39,54]. The expression of
dominant-negative dynamin mutants (dynamin
K44A) has been
shown to block the formation of clathrin-coated pits and vesicles
[55,56]. These observations have prompted us to investigate
whether dynamin may also play a role in EV71 entry mechanism.
Dynamin-2 expression could be inhibited after 24 and 48 hours of
3T3-SCARB2 cells transfected with 200 pmoles of dynamin-2-
specific siRNA as judged by the detection of dynamin (,100 KDa)
in the immunoblot assay (the top panel of Fig. 6). Dynamin-2-
specific siRNA pretreatment of 3T3-SCARB2 cells affected the
EV71 virus replication in a dose-dependent manner. The
production of viral capsid proteins was completely inhibited in
cells transfected with 200 pmoles of dynamin-2 siRNA, whereas
only moderate inhibition of viral capsid protein was seen in cells
treated with 100 pmoles of dynamin-2 siRNA (Fig. 6). Our
observations confirm that dynamin plays a crucial role in EV71
endocytosis through clathrin-mediated pathway.
EV71 entry is independent of caveolae
Besides clathrin-dependent endocytosis, other alternate mech-
anisms have been described to be involved in viral entry. Caveolae
have been implicated in the uptake of viruses such as SV40,
polyomavirus, ebola virus, echovirus I, lentivirus, and others
[28,31,32,33,34,57]. In the study of caveolae-mediated virus entry,
genistein, a tyrosine kinase inhibitor, can interrupt caveolae-
mediated endocytosis [58,59,60], and filipin, a cholesterol-binding
agent, is capable of disrupting the caveolar structure and function
[61,62,63], were subjected to test the ability in the inhibition of
EV71 infection using a two-fold of the maximally effective dose
that has been reported [58,61,62]. 3T3-SCARB2 cells were
treated with genistein prior to the infection with EV71. Maximal
dose of 20 mg/mL genistein had no inhibitory effect on the
endocytosis of EV71 in infected 3T3-SCARB2 cells (Fig. 7A), as
Figure 5. EV71 infection is impacted by clathrin specific inhibitors. (A) 3T3-SCARB2 cells were pretreated with different doses of CPZ for one
hour prior to the addition of MOI=0.04 of EV71. (B) 50 or 100 pmoles of siRNA specific to clathrin or 100 pmoles of control siRNA (MOCK) were
transfected to 3T3-SCARB2 cells as following the treatment protocol as Figure 4 described above. After 24 or 48 hours of transfection, cells were
following lysed and detected the content of clathrin light chain B (CLTB) by Western blot using anti-clathrin antibody. Relative expression of siRNA-
targeting genes shown in the top panel represented the relative CLTB protein levels of the cells transfected with specific siRNA, compared to the
expression in 48 hours transfection of the cells with 100 pmoles control siRNA (Mock) as 1.0 was shown. Lysates were also prepared after 24 or
48 hours of EV71 infection and subjected to analyze the expression of synthetic EV71 capsid protein by western blot using MAB979 antibody. The
result was shown in the lower panel. Cellular b-actin was detected by blotting the same membrane with monoclonal anti-b-actin antibody. Data
represent one of two independent experiments.
doi:10.1371/journal.pone.0030507.g005
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with the same dose of genistein was significantly resistant to
lentivirus-eGFP infection (Fig. 7B). Similar result was observed in
3T3-SCARB2 cells pre-treated with the maximal dose of 2 mg/mL
filipin that had no inhibition in EV71 entry into 3T3-SCARB2
cells (Fig. 8A). It was in contrast to the significant suppression of
the uptake of alexa fluor 594 cholera toxin subunit B (CT-B)
conjugate in 3T3-SCARB2 cells by the same dose of filipin
(Fig. 8B). The mechanism of cholera toxin internalization through
caveolae endocytosis has been confirmed [62]. Caveolin riched in
NIH3T3 cells was known [64]. We further knocked down the
endogenous caveolin-1 (CAV-1) by specific siRNA. Caveolin
expression could be inhibited after 24 and 48 hours of 3T3-
SCARB2 cells transfected with 100 pmoles of CAV-1 siRNA as
judged by immunoblot of the caveolin (22 KDa) (the top panel of
Fig. 8C). However, 3T3-SCARB2 cells pre-treated with CAV-1
siRNA did not resist from EV71 infection (Fig. 8C). These results
show clearly that EV71 entry using SCARB2 receptor is through
clathrin- but not caveolae-dependent endocytosis.
EV71 endocytosis is dependent on endosomal pH and
intact membrane cholesterol
Generally, enveloped viruses attach to the host cells through
bind to the receptor on the surface of host and then enter either at
acidic pH or at neutral pH. Acidic pH-dependent group includes
VSV, influenza A virus, adenovirus and rubella virus [65]. Some
viruses like RSV, SV40, measles virus, herpes simplex virus I,
vaccinia virus and HIV-1 are insensitive to lysosomotropic agents
[27,65,66,67] which are able to block endosomal acidification. For
most viruses using clathrin-mediated endocytosis, transition from
early-to-late stage endosome is pH-dependent [65]. After endocy-
tosis, viruses containing early endosmoes are configured to form
acidic (pH 6.0 to 6.5) vesicles and become progressively more
acidic as they mature to form late endosomes (pH 5.5 to 6.0).
Progressive acidification of endosomes is required for the
internalized viruses to establish their infection [65,68].
Specific compounds like NH4Cl [27,60] and chloroquine
[26,27,60] are capable of inhibiting endosomal acidification and
therefore employed to verify whether this phenomenon is
Figure 6. EV71 infection is blocked by dynamin-2 specific siRNA. 3T3-SCARB2 cells were treated with 100 and 200 pmoles of dynamin-2
siRNA or 200 pmole of control siRNA (MOCK) prior to the infection of EV71 as following the treatment protocol as Figure 4 described above. After 24
or 48 hours of transfection, the detection of dynamin-2 by western blot using anti-dynamin antibody was conducted, or following the transfectants
were infected with MOI=0.04 of EV71 and incubated for 24 or 48 hours before lysate preparation. Expression of dynamin-2 in the lysates was shown
in the top panel. Relative dynamin-2 protein levels in specific siRNA-treated cells compared to the levels in 48 hours of cells transfected with 200
pmoles control siRNA (Mock) as 1.0 was shown. The lower panel showed the expression of EV71 capsid protein which was detected by western
blotting of MAB979 antibody. Cellular b-actin was detected by blotting the same membrane with monoclonal anti-b-actin antibody. Data represent
one of two independent experiments.
doi:10.1371/journal.pone.0030507.g006
Mechanism of EV71 Entry in SCARB2-Expressing Cells
PLoS ONE | www.plosone.org 9 January 2012 | Volume 7 | Issue 1 | e30507consequential for EV71 infection. 3T3-SCARB2 cells were treated
with varied concentrations of NH4Cl or chloroquine prior to
EV71 infection. It was observed that NH4Cl was able to inhibit
EV71 capsid protein synthesis at concentration as low as 5 mM,
while chloroquine showed a dose-dependent inhibition at the
concentration of 5 mM with the maximal effect seen at 80 mM
compared to untreated cells (Fig. 9A). These observations confirm
that endocytosis of EV71 is pH dependent.
Cholesterol is required for receptor-mediated endocytosis of
viruses via CCPs [69] and is essential for the structure and function
of invaginated caveolae and caveolae-dependent endocytosis
[70,71,72]. Both clathrin- and caveolae-mediated endocytosis
require intact membrane cholesterol and are perturbed by methyl
b-cyclodextrin (MbCD), an agent that removes cholesterol from
the plasma membrane [73]. Pretreatment of 3T3-SCARB2 cells
with various concentrations of MbCD prior to infection with
EV71 revealed that MbCD was capable of inhibiting capsid
protein synthesis in a dose-dependent manner (Fig. 9B). Viability
of 3T3-SCARB2 cells was almost 100% at MbCD concentration
of 4 mM or less, but cytotoxicity was observed at MbCD
concentration of 8 mM (data not shown). Our results indicate
that intact cell membrane cholesterol is essential for EV71 entry by
clathrin-mediated endocytosis.
Our observations demonstrate that the route of internalization
of EV71 particles in SCARB2-expressing cells involves clathrin,
dynamin and is dependent on endosomal acidification and
membrane cholesterol level.
Discussion
Productive infection of target cells by viruses requires entry
pathways that allow viral components to be introduced into the
cytoplasm for subsequent processes such as uncoating, gene
expression, and replication. Previous studies with EV71 indicate
that SCARB2 [17] and PSGL-1 [16] serve as cellular receptors for
EV71 infection. Although endogenous mouse SCARB2 expressed
by NIH3T3 cells has 85.8% homology to human SCARB2, it
seems not to participate in the acute infection of NIH3T3 cells
with EV71. Only 3T3-SCARB2 cells that overexpress human
SCARB2 were highly susceptible to EV71, confirming that the
expressed human SCARB2 serves as a receptor conferring
susceptibility to EV71 infection. We have also observed that
NIH3T3 cells cultured with EV71 for a long time (.5 days),
showed some non-specific infection and replication of the virus, as
indicated by the cytopathic effect and plaque formation (data not
shown). This might be due to either mouse SCARB2 or some
other cell surface protein functioning as a receptor for EV71, albeit
with very low specificity. Mouse SCARB2 is a poor receptor for
EV71 infection of mouse cells was also confirmed by Yamayoshi
et al. [74]. In addition, Vero cells that are used as hosts for EV71
Figure 7. EV71 entry was not affected by a tyrosine kinase inhibitor treatment. (A) Pretreatment of 3T3-SCARB2 cells with 20, 10, and 5 mg/
mL of genestin for one hour before MOI=0.04 of EV71 infection was conducted. After one hour infection, the cells were incubated for 24 hours. Cells
lysate were further prepared and subjected to western blot using MAB979 antibody to detect EV71 capsid protein. The internal cellular b-actin was
detected by blotting the same membrane with monoclonal anti-b-actin antibody. (B) As a positive control of genistein inhibitory effect, A549 cells
were pre-treated with vehicle or 20 mg/mL of genistein for one hour before infected with MOI=0.1 of lentivirus-eGFP, and then following the cell
culture until 72 hours incubation. Cells without lentivirus-eGFP infection as negative control were also included. The same field of fluorescent and
visible pictures was taken under the UV-fluorescent microscopy and GFP-positive cells were counted.
doi:10.1371/journal.pone.0030507.g007
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SCARB2 but no expression of PSGL-1 confirming earlier
observation [16]. It is possible that the apparently low expression
of SCARB2 in Vero cells might be due to low affinity of the
experimental-used anti-SCARB2 polyclonal antibody towards
green monkey SCARB2. Additionally, siRNA specific to SCARB2
could not inhibit EV71 infection in Vero cells even though the
expression level of SCARB2 was impaired (Fig. 5), indicating that
in these cells some other protein functions as a receptor for EV71
entry.
The interaction between SCARB2 receptor and EV71 capsid
protein in 3T3-SCARB2 cells infected with EV71 has been clearly
demonstrated by co-immunoprecipitation. In addition to ensure
the role of SCARB2 as a receptor for EV71, our study also reveals
that EV71 enters cells through clathrin- and dynamin-dependent
endocytosis with progressive acidification of the endosomes.
Similar pathways have been reported to be employed by other
viruses. Polio virus uses CD155, a member of the immunoglobulin
superfamily as a receptor to infect host cells [76,77,78] and enters
the cells independent of clathrin and endosomal acidification [79].
RSV enters the cells through clathrin-mediated endocytosis at
neutral pH [27,80]. Influenza virus enters target cells by both
clathrin-dependent and -independent pathways of endocytosis
[81,82].
It has been reported that upon endocytosis, the native viral
particles containing the genomic viral RNA form subviral ‘‘A-
particles’’ sedimenting at 135S, which then undergo a conforma-
tional change to create subviral ‘‘B-particles’’ that sediment at 80S
induced by the low pH (#5.6) at the endocytic carrier vesicles and
late endosomes. Release of viral RNA from the protein shell of ‘‘B-
particles’’ facilitates viral replication [55,83,84]. This antigenic
conversion mediated by low pH is decreased in potassium-
depleted cells [55]. Therefore, the resulting acidification of the
endosomal environment would have enhanced the conversion of
Figure 8. Caveolae-independence of EV71 entry. (A) Pretreatment of 3T3-SCARB2 cells with 2. 1, and 0.5 mg/mL of filipin was conducted as the
same condition as the legend of Fig. 7A described above. Cells lysates were analyzed by western blot using MAB979 antibody to detect EV71 capsid
protein. The internal cellular b-actin was also detected by blotting the same membrane. (B) Uptake of 5 mg/mL CT-B conjugated with alexa fluor 594
in 3T3-SCARB2 cells treated with 2 mg/mL of filipin or vehicle (0.1% DMSO) was conducted following the protocol described in the Materials and
Methods. The same field of fluorescent and visible pictures was taken under confocal microscopy. (C) Transfection of 3T3-SCARB2 cells with 100
pmoles of caveolin (CAV-1) siRNA or control siRNA or control siRNA (Mock) prior to the infection of EV71 as following the treatment protocol as
Figure 4 described above was conducted. Expression of CAV-1 in the lysates was shown in the top panel. Relative expression of CAV-1 in specific
siRNA-treated cells compared to the protein levels in 48 hours of cells transfected with 100 pmoles control siRNA (Mock) as 1.0 was shown. The lower
panel showed the expression of EV71 capsid protein which was detected by western blotting of MAB979 antibody. Cellular b-actin was detected by
blotting the same membrane with monoclonal anti-b-actin antibody. Data represent one of two independent experiments.
doi:10.1371/journal.pone.0030507.g008
Mechanism of EV71 Entry in SCARB2-Expressing Cells
PLoS ONE | www.plosone.org 11 January 2012 | Volume 7 | Issue 1 | e30507EV71 ‘‘B-particles’’ to release the viral RNA resulting in enhanced
expression of viral capsid proteins in the endosomal stage of EV71
infection.
In this study we confirm the role of SCARB2 as a receptor for
EV71 and determine its internalization pathway to involve
clathrin, dynamin and progressive acidification of endosomes.
Our study paves way for understanding EV71 infectious pathway
in human SCARB2 expressing cells and therefore is of
consequence in planning prophylactic as well as therapeutic
approaches to control EV71 infection.
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